Methazolamide, a carbonic anhydrase inhibitor, is a medication used to treat increased pressure inside the eye due to glaucoma….
Read More »Insulin Resistance’s Effects on Tissue Iron Stores and Cognitive Performance
BIO (brain iron overload) could be a potentially useful MRI biomarker for insulin resistance and obesity-associated cognitive dysfunction….
Read More »Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
The glucose-reducing drug empagliflozin (Jardiance) now has approval from the FDA after the drug maker corrected manufacturing problems that caused the agency to say “no” in March…. The sodium glucose cotransporter 2 (SGLT2) is indicated for improving glycemic control in adults with type 2 diabetes in conjunction with diet and …
Read More »Hypertension Control Can Prevent Renal Damage in Diabetics
Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially if they have poor glycemic control….
Read More »New Way to Regenerate Beta Cells in Type 1 Diabetes
A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells….
Read More »CDC: 40% of American Adults Will Develop Diabetes
In Hispanic men and women, and non-Hispanic black women, the projected increased risk is even higher, over 50%….
Read More »Depressive Symptoms, Antidepressant Use, and Risk of Diabetes in African-American Women
Use of antidepressants was associated with a 26% higher risk of diabetes….
Read More »Printed Educational Messages to Promote Retinal Screening Not Effective
In a Canadian study, printed educational messages (PEMs) aimed at family practitioners were not effective in promoting retinal screening among diabetes patients….
Read More »Plasma Copeptin a Potential Marker for CVD in Asymptomatic T2DM Patients
Copeptin concentration also correlated to plasma creatinine and to PAD in T2DM patients….
Read More »A Novel Treatment for Type 2 Diabetes Patients
Tests in mice of recombinant human tissue kallikrein-1 show promise….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.